Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis
- 1 February 1995
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Digestive Diseases and Sciences
- Vol. 40 (2), 296-304
- https://doi.org/10.1007/bf02065413
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Intermittent therapy with high-dose 5-aminosalicylic acid enemas for maintaining remission in ulcerative proctosigmoiditisDiseases of the Colon & Rectum, 1990
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987
- The influence of metabolic variation on analgesic nephrotoxicity. Experiments with the gunn ratPathology, 1982
- Incidence of sulphasalazine-induced male infertility.Gut, 1981
- Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's DiseaseNew England Journal of Medicine, 1980
- Is Plasma Level Monitoring of Sulfasalazine Indicated in the Treatment of Crohnʼs Disease or Ulcerative Colitis?Therapeutic Drug Monitoring, 1980
- Clinical Pharmacokinetics of SulphasalazineClinical Pharmacokinetics, 1976
- Red cell abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis.Gut, 1975
- Nephrotoxic Lesions from 5-Aminosalicylic AcidBMJ, 1972
- Comparison of Corticosteroid and Sulphasalazine Therapy in Ulcerative ColitisBMJ, 1962